GSK vet named CEO of Chi­na CAR-T JV with Kite; Co­herus fights back against Am­gen claims it stole trade se­crets

→ Richard Wang, the for­mer site chief for GSK in Shang­hai, is tak­ing the CEO’s job at Fo­s­un Kite, a joint ven­ture es­tab­lished by Kite Phar­ma and Shang­hai Fo­s­un to ad­vance Kite’s CAR-T $KITE to the mar­ket.

→Am­gen $AMGN has filed a law­suit against Co­herus Bio­Sciences $CHRS claim­ing theft of trade se­crets, ac­cord­ing to a state­ment from the biotech. And the Red­wood City, CA-based Co­herus says it plans to de­fend it­self vig­or­ous­ly, adding that Am­gen is sole­ly in­ter­est­ed in fend­ing off com­pe­ti­tion to peg­fil­gras­tim by mount­ing a de­lay­ing ac­tion in state court. “Co­herus re­mains com­mit­ted to the im­por­tant goal of bring­ing much-need­ed biosim­i­lar drugs to the mar­ket­place,” said CEO Den­ny Lan­fear in a state­ment. “We are con­fi­dent that we will pre­vail in this ac­tion and achieve our goals of in­creas­ing pa­tient ac­cess, in­tro­duc­ing com­pe­ti­tion and of­fer­ing biosim­i­lar prod­ucts at prices com­pet­i­tive with and low­er than those main­tained by Am­gen and oth­er large phar­ma­ceu­ti­cal com­pa­nies.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER